303 related articles for article (PubMed ID: 33130851)
1. High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease.
Zuber V; Gill D; Ala-Korpela M; Langenberg C; Butterworth A; Bottolo L; Burgess S
Int J Epidemiol; 2021 Jul; 50(3):893-901. PubMed ID: 33130851
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis.
Helgadottir A; Thorleifsson G; Snaebjarnarson A; Stefansdottir L; Sveinbjornsson G; Tragante V; Björnsson E; Steinthorsdottir V; Gretarsdottir S; Helgason H; Saemundsdottir J; Olafsson I; Thune JJ; Raja AA; Ghouse J; Olesen MS; Christensen A; Jacobsen RL; Dowsett J; Bruun MT; Nielsen K; Knowlton K; Nadauld L; Benediktsson R; Erikstrup C; Pedersen OB; Banasik K; Brunak S; ; Bundgaard H; Ostrowski SR; Sulem P; Arnar DO; Thorgeirsson G; Thorsteinsdottir U; Gudbjartsson DF; Stefansson K; Holm H
Eur J Prev Cardiol; 2022 Dec; 29(18):2374-2385. PubMed ID: 36125206
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota in combination with blood metabolites reveals characteristics of the disease cluster of coronary artery disease and cognitive impairment: a Mendelian randomization study.
Xu S; Liu Y; Wang Q; Liu F; Xian Y; Xu F; Liu Y
Front Immunol; 2023; 14():1308002. PubMed ID: 38288114
[TBL] [Abstract][Full Text] [Related]
4. The Associations of Genetically Predicted Plasma Alanine with Coronary Artery Disease and its Risk Factors: A Mendelian Randomization Study.
Huang X; Zhao JV
Am J Clin Nutr; 2023 Nov; 118(5):1020-1028. PubMed ID: 37640107
[TBL] [Abstract][Full Text] [Related]
5. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
[TBL] [Abstract][Full Text] [Related]
6. Dose-Response Associations of Lipid Traits With Coronary Artery Disease and Mortality.
Yang G; Mason AM; Wood AM; Schooling CM; Burgess S
JAMA Netw Open; 2024 Jan; 7(1):e2352572. PubMed ID: 38241044
[TBL] [Abstract][Full Text] [Related]
7. Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease.
Levin MG; Zuber V; Walker VM; Klarin D; Lynch J; Malik R; Aday AW; Bottolo L; Pradhan AD; Dichgans M; Chang KM; Rader DJ; Tsao PS; Voight BF; Gill D; Burgess S; Damrauer SM
Circulation; 2021 Aug; 144(5):353-364. PubMed ID: 34139859
[TBL] [Abstract][Full Text] [Related]
8. Causal relationships between the gut microbiome, blood lipids, and heart failure: a Mendelian randomization analysis.
Dai H; Hou T; Wang Q; Hou Y; Wang T; Zheng J; Lin H; Zhao Z; Li M; Wang S; Zhang D; Dai M; Zheng R; Lu J; Xu Y; Chen Y; Ning G; Wang W; Bi Y; Xu M
Eur J Prev Cardiol; 2023 Sep; 30(12):1274-1282. PubMed ID: 37195998
[TBL] [Abstract][Full Text] [Related]
9. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
Ference BA; Kastelein JJP; Ginsberg HN; Chapman MJ; Nicholls SJ; Ray KK; Packard CJ; Laufs U; Brook RD; Oliver-Williams C; Butterworth AS; Danesh J; Smith GD; Catapano AL; Sabatine MS
JAMA; 2017 Sep; 318(10):947-956. PubMed ID: 28846118
[TBL] [Abstract][Full Text] [Related]
10. Major lipids and lipoprotein levels and risk of blood pressure elevation: a Mendelian Randomisation study.
Liu W; Yang C; Lei F; Huang X; Cai J; Chen S; She ZG; Li H
EBioMedicine; 2024 Feb; 100():104964. PubMed ID: 38181703
[TBL] [Abstract][Full Text] [Related]
11. Investigating Effects of Plasma Apolipoprotein E on Ischemic Heart Disease Using Mendelian Randomization Study.
Li MY; Kwok MK; Schooling CM
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34203181
[TBL] [Abstract][Full Text] [Related]
12. Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study.
Zhang X; Geng T; Li N; Wu L; Wang Y; Zheng D; Guo B; Wang B
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615727
[TBL] [Abstract][Full Text] [Related]
13. Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions.
Burgess S; Freitag DF; Khan H; Gorman DN; Thompson SG
PLoS One; 2014; 9(10):e108891. PubMed ID: 25302496
[TBL] [Abstract][Full Text] [Related]
14. Mendelian randomization studies in coronary artery disease.
Jansen H; Samani NJ; Schunkert H
Eur Heart J; 2014 Aug; 35(29):1917-24. PubMed ID: 24917639
[TBL] [Abstract][Full Text] [Related]
15. Causal Associations of Circulating Lipids with Osteoarthritis: A Bidirectional Mendelian Randomization Study.
Meng H; Jiang L; Song Z; Wang F
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405941
[TBL] [Abstract][Full Text] [Related]
16. Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives.
Richardson TG; Wang Q; Sanderson E; Mahajan A; McCarthy MI; Frayling TM; Ala-Korpela M; Sniderman A; Smith GD; Holmes MV
Lancet Healthy Longev; 2021 Jun; 2(6):e317-e326. PubMed ID: 34729547
[TBL] [Abstract][Full Text] [Related]
17. Association between genetically proxied lipid-lowering drug targets, lipid traits, and amyotrophic lateral sclerosis: a mendelian randomization study.
Yan Z; Xu Y; Li K; Liu L
Acta Neurol Belg; 2024 Apr; 124(2):485-494. PubMed ID: 37889424
[TBL] [Abstract][Full Text] [Related]
18. Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
Gobeil É; Bourgault J; Mitchell PL; Houessou U; Gagnon E; Girard A; Paulin A; Manikpurage HD; Côté V; Couture C; Marceau S; Bossé Y; Thériault S; Mathieu P; Vohl MC; Tchernof A; Arsenault BJ
Eur Heart J; 2024 Mar; 45(9):707-721. PubMed ID: 38243829
[TBL] [Abstract][Full Text] [Related]
19. Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study.
Lin BD; Alkema A; Peters T; Zinkstok J; Libuda L; Hebebrand J; Antel J; Hinney A; Cahn W; Adan R; Luykx JJ
Int J Epidemiol; 2019 Oct; 48(5):1505-1514. PubMed ID: 31504541
[TBL] [Abstract][Full Text] [Related]
20. Genetically mimicked effects of ASGR1 inhibitors on all-cause mortality and health outcomes: a drug-target Mendelian randomization study and a phenome-wide association study.
Yang G; Schooling CM
BMC Med; 2023 Jul; 21(1):235. PubMed ID: 37400795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
